glp 1 for non obese GLP-1 Agonists In Obesity What is the pipeline for

Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD

These drugs induce a mean weight loss of 1.88kg and also lower blood pressure (mean: 2.46mmHg in systolic and 1.46mmHg in diastolic blood pressure).48 The EMPA-REG,49 CANVAS and CANVAS-R trials,50 conducted in patients with DM2 and high cardiovascular risk, showed empagliflozin and canagliflozin to reduce cardiovascular risk (including cardiovascular death, non-fatal myocardial infarction or non-fatal stroke, and hospital admission due to heart failure)

Kwong-Han K, Zunaina E, Hanizasurana H, Che-Badariah AA, Che-Maraina CH

Regeneron Newsroom.